Author Archives: Somi Igbene

OncoArendi, University of Michigan Team Up on New IPF Therapies

OncoArendi Therapeutics and the University of Michigan (U-M) have signed an option-to-license agreement, allowing the Poland-based biotech company to develop new therapies to treat fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). “We are thrilled to be partnering with the University of Michigan, one of the world’s leading research…

Daily Breathing Exercises Seen to Slow Progression in IPF Patients

Simple breathing exercises as an add-on therapy can safely slow lung function decline and improve quality of life in people with mild to moderate idiopathic pulmonary fibrosis (IPF), a small study reported. After six months of disease-tailored and daily breathing exercises, participants showed significant gains in several measures of…